Research ExplorerScientific StaffMartin Horstmann Publications

Prof. Dr. ID: 52993

Martin Horstmann

graph of relations
Affiliations
1 - 50 out of 90Page size: 50

Publications

  1. 1994

  2. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment.

    Horstmann, M., Erttmann, R. & Winkler, K., 1994, In: LANCET. 343, 8905, p. 1098-1099 8905.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 1995

  4. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.

    Krüger, W., Stockschläder, M., Rüssmann, B., Berger, C., Hoffknecht, M., Sobottka, I., Kohlschütter, B., Kroschke, G., Kröger, N. & Horstmann, M., 1995, In: BRIT J HAEMATOL. 91, 3, p. 684-690 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia transplanted with bone marrow from HLA-identical related donors

    Horstmann, M., Stockschläder, M., Kabisch, H. & Zander, A., 01.03.1995, In: BLOOD. 85, 5, p. 1404-5 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.

    Horstmann, M., Stockschläder, M., Krüger, W., Hoffknecht, M., Betker, R., Kabisch, H. & Zander, A., 01.08.1995, In: ANN HEMATOL. 71, 2, p. 77-81 5 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 1996

  8. Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation.

    Horstmann, M., Kroschke, G., Stockschläder, M., Betker, R., Krüger, W., Erttmann, R., Kabisch, H. & Zander, A., 1996, In: PEDIATR HEMAT ONCOL. 13, 1, p. 45-53 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values.

    Krüger, W., Sobottka, I., Stockschläder, M., Mross, K., Hoffknecht, M., Rüssmann, B., Horstmann, M., Betker, R. & Zander, A., 1996, In: SCAND J INFECT DIS. 28, 3, p. 313-316 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19).

    Horstmann, M., Argyriou-Tirita, A., Borkhardt, A., Kabisch, H., Kapaun, P., Winkler, K. & Haas, O. A., 1996, In: CANCER GENET-NY. 88, 2, p. 103-109 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Use of cryopreserved bone marrow in unrelated allogeneic transplantation.

    Stockschläder, M., Krüger, W., Tom Dieck, A., Horstmann, M., Altnöder, M., Löliger, C., Fiedler, W., Hoffknecht, M., Erttmann, R. & Zander, A., 1996, In: BONE MARROW TRANSPL. 17, 2, p. 197-199 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 1997

  13. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.

    Anderegg, B., Horstmann, M. & Kabisch, H., 1997, In: CANCER GENE THER. 4, 2, p. 84-90 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Frequent reduction or loss of DCC gene expression in human osteosarcoma.

    Horstmann, M., Pösl, M., Scholz, R. B., Anderegg, B., Simon, P., Baumgaertl, K., Delling, G. & Kabisch, H., 1997, In: BRIT J CANCER. 75, 9, p. 1309-1317 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.

    Zander, A. R., Berger, C., Kröger, N., Stockshläder, M., Krüger, W., Horstmann, M., Grimm, J., Zeller, W., Kabisch, H., Erttmann, R., Schönrock, P., Kuse, R., Braumann, D., Illiger, H. J., Fiedler, W., de Witt, M., Hossfeld, K. D. & Weh, H. J., 1997, In: CLIN CANCER RES. 3(12 Pt 2), p. 2671-2675

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay.

    Anderegg, B., Horstmann, M., Ernst, M. & Kabisch, H., 1997, In: PEDIATR HEMAT ONCOL. 14, 4, p. 349-358 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 1998

  18. alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome.

    Price, E. R., Horstmann, M., Wells, A. G., Weilbaecher, K. N., Takemoto, C. M., Landis, M. W. & Fisher, D. E., 1998, In: J BIOL CHEM. 273, 49, p. 33042-33047 49.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Treatment and long-term outcome of pineal nongerminomatous germ cell tumors.

    Knappe, U. J., Bentele, K. H. P., Horstmann, M. & Herrmann, H. D., 1998, In: PEDIATR NEUROSURG. 28, 5, p. 241-245 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3.

    Weilbaecher, K. N., Hershey, C. L., Takemoto, C. M., Horstmann, M., Hemesath, T. J., Tashjian, A. H. & Fisher, D. E., 02.03.1998, In: J EXP MED. 187, 5, p. 775-785 11 p., 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 1999

  22. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients.

    Dürken, M., Horstmann, M., Bieling, P., Erttmann, R., Kabisch, H., Löliger, C., Schneider, E. M., Hellwege, H. H., Krüger, W., Kröger, N., Zander, A. R. & Janka, G. E., 01.09.1999, In: BRIT J HAEMATOL. 106, 4, p. 1052-1058 7 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. 2000

  24. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

    Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M., Wells, A. G., Price, E. R., Fisher, D. Z. & Fisher, D. E., 2000, In: GENE DEV. 14, 3, p. 301-312 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2001

  26. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.

    Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z. & Fisher, D. E., 08.05.2001, In: P NATL ACAD SCI USA. 98, 10, p. 5798-5803 6 p., 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 2002

  28. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.

    McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y-L., Ramaswamy, S., Avery, W., Ding, H-F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R. & Fisher, D. E., 2002, In: CELL. 109, 6, p. 707-718 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.

    Kröger, N., Zabelina, T., Renges, H., Krüger, W., Kordes, U., Rischewski, J., Schrum, J., Horstmann, M., Ayuketang Ayuk, F., Erttmann, R., Kabisch, H. & Zander, A. R., 2002, In: ANN HEMATOL. 81, 11, p. 627-631 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor

    Widlund, H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X. & Fisher, D. E., 16.09.2002, In: J CELL BIOL. 158, 6, p. 1079-87 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. 2003

  32. Infantile cobalamin deficiency with cerebral lactate accumulation and sustained choline depletion.

    Horstmann, M., Neumaier-Probst, E., Lukacs, Z., Steinfeld, R., Ullrich, K. & Kohlschütter, A., 2003, In: NEUROPEDIATRICS. 34, 5, p. 261-264 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

    Du, J., Miller, A. J., Widlund, H. R., Horstmann, M., Ramaswamy, S. & Fisher, D. E., 2003, In: AM J PATHOL. 163, 1, p. 333-343 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. 2004

  35. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.

    Du, J., Widlund, H. R., Horstmann, M., Ramaswamy, S., Ross, K., Huber, W. E., Nishimura, E. K., Golub, T. R. & Fisher, D. E., 2004, In: CANCER CELL. 6, 6, p. 565-576 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. 2005

  37. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.

    Horstmann, M., Hassenpflug, W-A., Udo, Z. S., Escherich, G., Janka-Schaub, G. & Kabisch, H., 2005, In: HAEMATOLOGICA. 90, 12, p. 1701-1703 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.

    Stam, R. W., Boer, D., Monique, L., Schneider, P., Horstmann, M., Horstmann, M., Beverloo, H. B., van der Voort, E., Valsecchi, M. G., de Lorenzo, P., Sallan, S. E., Armstrong, S. A. & Pieters, R., 2005, In: BLOOD. 106, 7, p. 2484-2490 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels

    Horstmann, M., Merseburger, A. S., von der Heyde, E., Serth, J., Wegener, G., Mengel, M., Feil, G., Hennenlotter, J., Nagele, U., Anastasiadis, A., Bokemeyer, C., Stenzl, A. & Kuczyk, M., 11.2005, In: J CANCER RES CLIN. 131, 11, p. 715-22 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2006

  41. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains.

    Dierck, K., Machida, K., Voigt, A., Thimm, J., Horstmann, M., Fiedler, W., Mayer, B. J. & Nollau, P., 2006, In: NAT METHODS. 3, 9, p. 737-744 8 p., 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.

    Grotel, V., Martine, U., Meijerink, U., Jules, P. P., Beverloo, U., Berna, H., Langerak, U., Anton, W., Buys-Gladdines, U., Jessica, G. C. A. M., Schneider, U., Pauline, U., Poulsen, U., Tim, S., Den, B., Monique, L., Horstmann, M., Martin, U., Kamps, U., Willem, A., Veerman, U., Anjo, J. P., Wering, V., Elisabeth, R., Noesel, V., Max, M., Pieters, U. & Rob, U., 01.09.2006, In: HAEMATOLOGICA. 91, 9, p. 1212-1221 10 p., 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. 2007

  44. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.

    Metzner, A., Horstmann, M., Fehse, B., Ortmeyer, G., Niemeyer, C. M., Stocking, C., Mayr, G. W. & Jücker, M., 2007, In: GENE THER. 14, 8, p. 699-703 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 2008

  46. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.

    Van Vlierberghe, P., Homminga, I., Zuurbier, L., Gladdines-Buijs, J., van Wering, E. R., Horstmann, M., Beverloo, H. B., Pieters, R. & Meijerink, J. P. P., 2008, In: LEUKEMIA. 22, 4, p. 762-770 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.

    Balgobind, U., Brian, V., Vlierberghe, V., Pieter, U., van Den, O., Ans, M. W., Beverloo, U., Berna, H., Terlouw-Kromosoeto, U., Joan, N. R., Wering, V., Elisabeth, R., Reinhardt, U., Dirk, U., Horstmann, M., Martin, U., Kaspers, U., Gertjan, J. L., Pieters, U., Rob, U., Zwaan, U., Michel, C., Heuvel-Eibrink, V. D., Marry, M., Meijerink, U. & Jules, P. P., 2008, In: BLOOD. 111, 8, p. 4322-4328 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.

    Van Vlierberghe, P., Beverloo, H. B., Buijs-Gladdines, J., van Wering, E. R., Horstmann, M., Pieters, R. & Meijerink, J. P. P., 2008, In: LEUKEMIA. 22, 7, p. 1434-1437 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

    Pieter, V. V., van Grotel, M., Tchinda, J., Lee, C., Beverloo, H. B., Spek, V. D., Peter, J., Stubbs, A., Cools, J., Nagata, K., Fornerod, M., Horstmann, M., Horstmann, M., Wering, V., Elisabeth, R., Soulier, J., Pieters, R. & Meijerink, J. P. P., 2008, In: BLOOD. 111, 9, p. 4668-4680 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].

    Bhojwani, D., Kang, H., Menezes, R. X., Yang, W., Sather, H., Moskowitz, N. P., Min, D-J., Potter, J. W., Harvey, R., Hunger, S. P., Seibel, N., Raetz, E. A., Pieters, R., Horstmann, M. A., Relling, M. V., den Boer, M. L., Willman, C. L., Carroll, W. L. & Children's Oncology Group Study, 20.09.2008, In: J CLIN ONCOL. 26, 27, p. 4376-4384 9 p., 27.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. 2009

  52. WT1 mutations in T-ALL.

    Tosello, V., Mansour, M. R., Barnes, K., Paganin, M., Sulis, M. L., Jenkinson, S., Allen, C. G., Gale, R. E., Linch, D. C., Palomero, T., Real, P., Murty, V., Yao, X., Richards, S. M., Goldstone, A., Rowe, J., Basso, G., Wiernik, P. H., Paietta, E., Pieters, R., Horstmann, M., Meijerink, J. P. P. & Ferrando, A. A., 2009, In: BLOOD. 114, 5, p. 1038-1045 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

    Den, B., Monique, L., Slegtenhorst, V., Marjon, U., Menezes, D., Renée, X., Cheok, U., Meyling, H., Buijs-Gladdines, U., Jessica, G. C. A. M., Peters, U., Susan, T. C. J. M., Zutven, V., Laura, J. C. M., Beverloo, U., Berna, H., Spek, V. D., Peter, J., Escherich, G., Gaby, U., Horstmann, M., Martin, A., Janka-Schaub, G., Gritta, E., Kamps, U., Willem, A., Evans, U., William, E., Pieters, U. & Rob, U., 01.02.2009, In: LANCET ONCOL. 10, 2, p. 125-134 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 2010

  55. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.

    Zuurbier, L., Homminga, I., Calvert, V., Te Winkel, M. L., Buijs-Gladdines, J. G. C. A. M., Kooi, C., Smits, W. K., Sonneveld, E., Veerman, A. J. P., Kamps, W. A., Horstmann, M., Petricoin, E. F., Pieters, R. & Meijerink, J. P. P., 2010, In: LEUKEMIA. 24, 12, p. 2014-2022 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.

    Escherich, G., Horstmann, M. A., Zimmermann, M., Janka-Schaub, G. E. & COALL study group, 01.02.2010, In: LEUKEMIA. 24, 2, p. 298-308 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. 2011

  58. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

    Homminga, I., Pieters, R., Langerak, A. W., Rooi, D., Johan, J., Stubbs, A., Verstegen, M., Vuerhard, M., Buijs-Gladdines, J., Kooi, C., Klous, P., van Vlierberghe, P., Ferrando, A. A., Cayuela, J. M., Verhaaf, B., Horstmann, M., Horstmann, M., de Haas, V., Wiekmeijer, A-S., Pike-Overzet, K., Staal, F. J. T., de Laat, W., Soulier, J., Sigaux, F. & Meijerink, J. P. P., 2011, In: CANCER CELL. 19, 4, p. 484-497 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

    Zenatti, P. P., Ribeiro, D., Li, W., Zuurbier, L., Silva, M. C., Paganin, M., Tritapoe, J., Hixon, J. A., Silveira, A. B., Cardoso, B. A., Sarmento, L. M., Correia, N., Toribio, M. L., Kobarg, J., Horstmann, M., Pieters, R., Brandalise, S. R., Ferrando, A. A., Meijerink, J. P., Durum, S. K., Yunes, J. A. & Barata, J. T., 2011, In: NAT GENET. 43, 10, p. 932-939 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  60. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

    Escherich, G., Troeger, A. F., Gobel, U., Graubner, U., Pekrun, A., Jorch, N., Kaspers, G., Zimmermann, M., Zur Stadt, U., Kazemir, K., Pieters, R., Horstmann, M., Denboer, M. L. & Janka-Schaub, G., 2011, In: HAEMATOLOGICA. 96, 6, p. 854-862 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  61. 2012

  62. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.

    Ellinghaus, E., Stanulla, M., Richter, G., Ellinghaus, D., Te Kronnie, G., Cario, G., Cazzaniga, G., Horstmann, M., Panzer Grümayer, R., Cavé, H., Trka, J., Cinek, O., Teigler-Schlegel, A., ElSharawy, A., Häsler, R., Nebel, A., Meissner, B., Bartram, T., Lescai, F., Franceschi, C., Giordan, M., Nürnberg, P., Heinzow, B., Zimmermann, M., Schreiber, S., Schrappe, M. & Franke, A., 2012, In: LEUKEMIA. 26, 5, p. 902-909 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  63. In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.

    Terziyska, N., Catarina, C. A., Groiss, V., Schneider, K., Farkasova, K., Ogris, M., Wagner, E., Ehrhardt, H., Brentjens, R. J., Zur Stadt, U., Horstmann, M., Quintanilla-Martinez, L. & Jeremias, I., 2012, In: PLOS ONE. 7, 12, p. 52798 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  64. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.

    Brauer, H., Strauss, J., Wegner, W., Müller-Tidow, C., Horstmann, M. & Jücker, M., 2012, In: CELL SIGNAL. 24, 11, p. 2095-2101 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  65. Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR).

    Weber, A., Taube, S., Zur Stadt, U., Horstmann, M., Krohn, K., Bradtke, J., Teigler-Schlegel, A., Leiblein, S. & Christiansen, H., 2012, In: EXP HEMATOL ONCOL. 1, 1, p. 33 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  66. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.

    Zuurbier, L., Petricoin, E. F., Vuerhard, M. J., Calvert, V., Kooi, C., Buijs-Gladdines, J. G. C. A. M., Smits, W. K., Sonneveld, E., Veerman, A. J. P., Kamps, W. A., Horstmann, M., Pieters, R. & Meijerink, J. P. P., 2012, In: HAEMATOLOGICA. 97, 9, p. 1405-1413 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  67. 2013

  68. Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients.

    Meyer, C., Zur Stadt, U., Escherich, G., Hofmann, J., Binato, R., Barbosa, T. D. C., Emerenciano, M., Pombo-de-Oliveira, M. S., Horstmann, M. & Marschalek, R., 2013, In: AM J BLOOD RES. 3, 2, p. 165-173 9 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  69. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial

    Escherich, G., Zur Stadt, U., Zimmermann, M., Horstmann, M. A. & COALL study group, 01.10.2013, In: BRIT J HAEMATOL. 163, 2, p. 240-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  70. Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells

    Hartsink-Segers, S. A., Exalto, C., Allen, M., Williamson, D., Clifford, S. C., Horstmann, M., Caron, H. N., Pieters, R. & Den Boer, M. L., 01.10.2013, In: HAEMATOLOGICA. 98, 10, p. 1539-46 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next